The electroretinogram, commonly known as ERG, is a diagnostic tool used by ophthalmologists and vision scientists to objectively measure the electrical activity generated by the retina of the eye in response to a light stimulus. An ERG provides valuable information about the overall function of the retina and can help detect various retinal disorders. In recent years, ERG technology has advanced significantly and is now being used globally to study retinal diseases and assess treatment outcomes on a wider scale.
What is an ERG?
An ERG is a noninvasive test that uses contact lens electrodes placed on the surface of the eye to record the summed electrophysiological response of different retinal cell types – photoreceptors, bipolar cells, amacrine cells and ganglion cells – resulting from a series of standardized light flashes or patterns. The recorded ERG waveform consists of positive and negative deflections representing the activity of various retinal layers stimulated by light. Based on the stimulating conditions, ERGs can be divided into full-field ERG and multifocal ERG.
Full-field ERG assesses overall retinal function by involving the entire retinal surface using large, diffuse flashes of light presented from a Ganzfeld dome or contact lens electrodes. The major components of full-field ERG recorded are the a-wave representing photoreceptor function and the b-wave representing ON-bipolar cell function. Multifocal ERG divides the retina into segments and stimulates each segment separately with scaled m-sequences of light flashes. It provides a topographical map of local retinal responses and is more sensitive in detecting retinal abnormalities.
Growing Significance of ERG Globally
ERG has emerged as a valuable clinical test for evaluating retinal diseases like retinitis pigmentosa and diabetic retinopathy. With the rising prevalence of retinal disorders worldwide due to aging populations and lifestyle changes, more eye care professionals are utilizing ERG to objectively diagnose and monitor disease progression and treatment responses. Several multi-centered international collaborative studies are ongoing involving ERG end points to develop therapies for various retinal degenerations. Standardized ERG protocols and reference databases have been proposed to allow uniform interpretation of results across sites.
Advances in ERG Technology
Advances in technology have made Global Electroretinogram testing more feasible and repeatable. Computerized systems have automated stimulus generation and analysis of ERG waveforms, which has led to more widespread clinical use. Jet or microdrop dispenser contact lenses are used for stimulating smaller and isolated retinal areas during multifocal ERG. Infrared fundus cameras and retinal tracking systems integrated with ERG machines enable recording of ERG responses mapped over fundus image for precise functional localization. Novel stimulators like ganzfeld domes and LED goggles produce uniform, stable and repeatable full-field light stimuli. These developments have enhanced portability and standardization of ERG testing, facilitating global collaborative research.
ERG in Assessing Retinal Disease Management
ERG is playing an increasingly important role in objectively gauging treatment responses in retinal diseases worldwide. For example, in clinical trials of gene therapies for inherited retinal dystrophies like retinitis pigmentosa, ERG measures serve as primary endpoints to determine functional rescue following treatment. Similarly, in diabetes eye diseases, changes in ERG amplitudes indicate effects of anti-VEGF drugs, laser photocoagulation or retinal cell transplantation on halting retinal cell loss.
Longitudinal ERG monitoring along with other modalities like optical coherence tomography (OCT) and fundus autofluorescence helps ophthalmologists accurately stage disease severity, assess risks and evaluate new therapies to preserve vision for patients. Large natural history studies involving ERG combined with genetic testing have expanded our understanding of various inherited retinal disorders and their clinical management. Multicenter research projects are underway globally to define ERG biomarkers that correlate with visual prognosis, allowing individualized care approaches.
Future ERG Applications
With steadily improving recording techniques and computational processing of ERG data, newer applications of ERG are emerging. For instance, analysis of oscillatory potentials recorded within the ERG waveform may identify subtle retinal changes not evident on standard clinical tests. Advances in signal extraction approaches from multifocal ERG responses promise faster, more detailed maps of localized retinal function. Researchers are exploring combination technologies for simultaneous collection of ERG, OCT and other modalities to generate comprehensive functional/structural maps for enhanced evaluation retinal pathologies.
Additionally, noninvasive techniques for recording ERG signals from inside the eye using electrodes implanted temporarily hold promise for continuous ambulatory monitoring of retinal function in real-world settings over time. With continued worldwide collaboration, new applications leveraging ERG’s unparalleled ability to gauge retinal integrity is likely to transform clinical management and research into blinding eye diseases globally in the years to come.
The electroretinogram is a versatile, objective assessment tool for retinal function that has significantly advanced our understanding of retinal disorders and treatment outcomes worldwide. Advances in ERG technology and global collaboration will continue to expand its clinical and research applications with the ultimate goal of improving vision outcomes on a global scale.
For more insights, read- https://www.pressreleasebulletin.com/global-electroretinogram-trends-size-and-share-analysis/
Comments
0 comment